Morgan Stanley 13D and 13G filings for Nurix Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-07 5:37 pm Sale |
2024-09-30 | 13G | Nurix Therapeutics, Inc. NRIX |
MORGAN STANLEY MS |
1,758,053 2.700% |
-1,341,145 (-43.27%) |
Filing |
| 2024-02-09 1:47 pm Purchase |
2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX |
MORGAN STANLEY MS |
3,099,198 6.400% |
3,099,198 (New Position) |
Filing |